Hermansky-Pudlak syndrome due to BLOC-3 deficiency Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

Regulatory Watchboard

No FDA or trial events recorded yet for Hermansky-Pudlak syndrome due to BLOC-3 deficiency.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Hermansky-Pudlak syndrome due to BLOC-3 deficiency.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Jascayd

(NERANDOMILAST)Orphan drugstandard

Boehringer Ingelheim Pharmaceuticals, Inc.

12.1 Mechanism of Action Nerandomilast is an inhibitor of phosphodiesterase 4 (PDE4) with at least nine-fold preferential inhibition of the PDE4B isoe...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Hermansky-Pudlak syndrome due to BLOC-3 deficiency.
Search all trials →

Search clinical trials for Hermansky-Pudlak syndrome due to BLOC-3 deficiency →

Recent News & Research

No recent news articles indexed yet for Hermansky-Pudlak syndrome due to BLOC-3 deficiency.
Search PubMed for Hermansky-Pudlak syndrome due to BLOC-3 deficiency →

Browse all Hermansky-Pudlak syndrome due to BLOC-3 deficiency news →

Specialist Network

No specialists currently listed for Hermansky-Pudlak syndrome due to BLOC-3 deficiency.

View all Hermansky-Pudlak syndrome due to BLOC-3 deficiency specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰